Andreas Pharma Private Limited, a active private limited company, was established on 29 September 2017 in Vasai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U36999MH2017PTC300287. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹5.00 M.
It upholds a compliant status. Its leadership includes Ashish Jagtamba Singh (Director), Saurabh Kumar Singh (Director), Ujjwal Nityanand Jha (Director). Past directors included Ved Prakash Singh, Sandip Gangopadhyay, Ajeya Kumar. It holds ₹2.05 Cr open charges and ₹6.00 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gala No.206, B-1,, Prime Trade Center Ind.Est, Vasai, Maharashtra, 401208.
U36999MH2017PTC300287
300287
29 September 2017
₹5.00 M
₹5.00 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Andreas Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ashish Jagtamba Singh | Director | 29 Sep 2017 | Current |
| Saurabh Kumar Singh | Director | 27 Dec 2019 | Current |
| Ujjwal Nityanand Jha | Director | 15 Feb 2022 | Current |
| Indraraj Neogi | Director | 15 Feb 2022 | Current |
| Vinay Kumar Singh | Director | 27 Dec 2019 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 27 Dec 2019 | Past |
| Pramod Abcsdd | Director | 17 Feb 2021 | Past |
| Pramod Abcsdd | Additional Director | 27 Dec 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Andreas Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 674.06% increase. The company also saw a substantial improvement in profitability, with a 1204.06% increase in profit. The company's net worth Soared by an impressive increase of 3269.16%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Andreas Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹20,520,000.00
₹6,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Oct 2024 | Others | ₹2.00 Cr | Open |
| 31 Oct 2023 | Others | ₹0.52 M | Open |
| 26 Jul 2023 | Hdfc Bank Limited | ₹6.00 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Andreas Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Andreas Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Andreas Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 26 Jul 2023 via Charge ID 100773725 with Hdfc Bank Limited was fully satisfied on 10 Nov 2025. was completed.
The activity A charge with Others amounted to Rs. 20.00 M with Charge ID 101017621 was registered on 03 Oct 2024. was completed.
Andreas Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Andreas Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on A charge with Others amounted to Rs. 0.52 M with Charge ID 100817148 was registered on 31 Oct 2023. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 6.00 M with Charge ID 100773725 was registered on 26 Jul 2023. was completed.
The CIN of Andreas Pharma Private Limited is U36999MH2017PTC300287.
Andreas Pharma Private Limited is headquartered at Gala No.206, B-1,, Prime Trade Center Ind.Est, Vasai, Maharashtra, 401208.
Andreas Pharma Private Limited was incorporated on 29 September 2017.
The current directors of Andreas Pharma Private Limited are
The primary industry of Andreas Pharma Private Limited is Manufacturing.
Andreas Pharma Private Limited is unlisted.
The authorized capital of Andreas Pharma Private Limited is ₹5.00 M, and the paid-up capital is ₹5.00 M.
The compliance status of Andreas Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX